<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974086</url>
  </required_header>
  <id_info>
    <org_study_id>21-018609</org_study_id>
    <secondary_id>K23MH119976</secondary_id>
    <nct_id>NCT04974086</nct_id>
  </id_info>
  <brief_title>Electronic Sexual Reproductive Health CDS Tool at the Children's Hospital of Philadelphia</brief_title>
  <official_title>Feasibility and Acceptability of an Electronic Clinical Decision Support Tool for Adolescent Sexual and Reproductive Health Services</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many studies show early detection of sexual activity in adolescents can improve their health&#xD;
      management and that primary care pediatricians would benefit from supports to address&#xD;
      adolescent health, including sexual and reproductive health. The primary objective of this&#xD;
      study is to evaluate the feasibility, acceptability, and usability of a sexual and&#xD;
      reproductive health (SRH) services clinical decision support (CDS) tool within the electronic&#xD;
      health record (EHR) among clinicians, adolescent patients, and their parents. Secondary&#xD;
      objectives include assessment of the CDS tool's impact on clinical measures. The SRH CDS tool&#xD;
      will be embedded within clinical practice and evaluated through a single-armed prospective&#xD;
      cohort study of primary care clinicians, adolescent patients, and parents. The SRH CDS tool&#xD;
      that will support pediatric clinicians by providing evidence-based sexual health-related&#xD;
      screening, treatment, and referrals, as needed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SRH CDS tool will be embedded within the electronic health record (EHR) and will be&#xD;
      evaluated to include feasibility (through medical record review for EHR utilization data),&#xD;
      pediatric clinician acceptability and usability of the intervention (using surveys and&#xD;
      semi-structured interviews), and adolescent and parent acceptability of the approach (using&#xD;
      surveys). The secondary outcomes include measures of clinical impact, including ordering (and&#xD;
      the results) of screening labs, prescribing of contraception and/or human immunodeficiency&#xD;
      virus (HIV) pre-exposure prophylaxis, referrals to additional adolescent health services, and&#xD;
      follow-up with those services.&#xD;
&#xD;
      Three cohorts of participants will be involved in the study: 1) Clinicians (attending&#xD;
      physicians, nurse practitioners, and pediatric residents), 2) their English-speaking&#xD;
      adolescent patients, and 3) their parents at included primary care sites.&#xD;
&#xD;
      The first 100 adolescent patients for whom the CDS tool is used will be approached in-person&#xD;
      or remotely via text message or phone call after the clinical visit to complete a brief&#xD;
      survey on the acceptability of the treatment provided at the visit, acceptability of that&#xD;
      treatment, satisfaction with potential treatment outcomes, and if they engaged in any&#xD;
      conversations with their parent(s) about any treatment provided at the visit.&#xD;
&#xD;
      Similarly, parents of those first 100 adolescent patients will be approached in-person or&#xD;
      remotely via text message or phone call after the clinical visit to complete a brief survey&#xD;
      on the acceptability of the approach to adolescent care workflow (not any specifics about the&#xD;
      actual care provided) as well as any conversations about the visit that occurred between the&#xD;
      parent and adolescent after the visit. Contact information, including phone number, for&#xD;
      potential adolescent and parent participants will be retrieved from the adolescent's medical&#xD;
      record. Additionally, Investigators will approach 50 pediatric clinicians in-person or&#xD;
      remotely via email to complete a brief survey and semi-structured interview on the&#xD;
      feasibility, acceptability, and usability of the CDS tool. Pediatric clinicians are eligible&#xD;
      if they care for adolescent patients and have used the SRH CDS tool in practice.&#xD;
&#xD;
      Results from clinician surveys and semi-structured interviews will ensure that the CDS tool&#xD;
      design meets clinicians' needs - ensuring a level of usability, functionality, and usefulness&#xD;
      that supports pediatric clinicians' delivery of sexual and reproductive health care services&#xD;
      to adolescents.&#xD;
&#xD;
      Secondary outcome measures aimed at assessing the clinical impact of the CDS tool include:&#xD;
&#xD;
        -  Number of contraception or HIV pre-exposure prophylaxis prescriptions written as a&#xD;
           result of the CDS tool,&#xD;
&#xD;
        -  Number of gonorrhea, chlamydia, syphilis, HIV, and pregnancy tests ordered as a result&#xD;
           of the CDS tool,&#xD;
&#xD;
        -  Number of positive gonorrhea, chlamydia, syphilis, HIV, and pregnancy tests ordered as a&#xD;
           result of the CDS tool,&#xD;
&#xD;
        -  And, the percentage of adolescents who successfully follow-up with the Adolescent&#xD;
           Medicine Division.&#xD;
&#xD;
      This study presents no more than minimal risk to study participants, as this is a study aimed&#xD;
      to assess the creation of a tool that helps to improve upon the current delivery of SRH&#xD;
      services provided through pediatric primary care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single arm prospective cohort study</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Usability of a sexual and reproductive health (SRH) services clinical decision support (CDS) tool among clinicians as assessed by the SUS.</measure>
    <time_frame>1 day</time_frame>
    <description>The System Usability Scale (SUS) is a validated 10-item tool used for measuring subjective assessments of usability. This survey will be presented to pediatric clinicians using the SRH CDS tool and they will be asked to rate how much they agree/disagree with 10 statements related to the tool's usability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of a sexual and reproductive health (SRH) services clinical decision support (CDS) tool among clinicians as assessed through qualitative interviews.</measure>
    <time_frame>1 day</time_frame>
    <description>Qualitative interviews will be conducted with pediatric clinicians who use the SRH CDS tool. This interview will be one-on-one and ask questions that assess attitudes towards using the tool, feasibility of consistently using the tool in practice, and feedback on how to improve the tool.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of a sexual and reproductive health (SRH) services clinical decision support (CDS) tool among adolescents</measure>
    <time_frame>1 day</time_frame>
    <description>This will be measured through a survey for adolescents who presented for a well child care visit and completed the Adolescent Health Questionnaire (a health screener used as standard care in all well child care visits). The survey consists of 44 questions about acceptability of a questionnaire part of standard well visits and of potential SRH services they received during their visit, attitudes towards privacy of their visit and discussions with their provider, &amp; feedback on discussions that occurred between them and a parent/guardian after their visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability of a sexual and reproductive health (SRH) services clinical decision support (CDS) tool among parents of adolescents</measure>
    <time_frame>1 day</time_frame>
    <description>This will be measured through a survey for parents of adolescents who were present during their child's well child care visit. The survey consists of 15 questions about acceptability of a questionnaire that includes SRH-related questions part of standard well care, acceptability of their child receiving confidential services part of standard well care, &amp; feedback on discussions that occurred between them and their child after their visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the CDS tool's impact on the number of prescriptions written</measure>
    <time_frame>up to 2 years</time_frame>
    <description>This will be measured by the difference in pre- and post-intervention metrics for the number of contraception or human immunodeficiency virus (HIV) pre-exposure prophylaxis prescriptions written as a result of the CDS tool. These metrics will be measured by pre- and post-intervention data analytics provided by the Children's Hospital of Philadelphia (CHOP) Department of Biomedical and Health Informatics (DBHI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the CDS tool's impact on the number of sexually transmitted infection/human immunodeficiency virus (STI/HIV) and pregnancy tests ordered</measure>
    <time_frame>up to 2 years</time_frame>
    <description>This will be measured by the difference in pre- and post-intervention metrics for the number of STI/HIV and pregnancy tests ordered as a result of the CDS tool. These metrics will be measured by pre- and post-intervention data analytics provided by the Children's Hospital of Philadelphia (CHOP) Department of Biomedical and Health Informatics (DBHI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the CDS tool's impact on the number of positive STI/HIV and pregnancy tests</measure>
    <time_frame>up to 2 years</time_frame>
    <description>This will be measured by the difference in pre- and post-intervention metrics for the number of positive STI/HIV and pregnancy tests as a result of the CDS tool. These metrics will be measured by pre- and post-intervention data analytics provided by the Children's Hospital of Philadelphia (CHOP) Department of Biomedical and Health Informatics (DBHI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the CDS tool's impact on the percentage of adolescents who successfully follow-up with the Adolescent Medicine Division</measure>
    <time_frame>up to 2 years</time_frame>
    <description>This will be measured by the difference in pre- and post-intervention metrics for the percentage of adolescents who successfully follow-up with the Adolescent Medicine Division as a result of the CDS tool. These metrics will be measured by pre- and post-intervention data analytics provided by the Children's Hospital of Philadelphia (CHOP) Department of Biomedical and Health Informatics (DBHI).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Sexual and Reproductive Health</condition>
  <arm_group>
    <arm_group_label>CDS Tool Evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will receive intervention and feasibility, acceptability, and usability of intervention will be assessed from each participant cohort group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sexual and reproductive health (SRH) services</intervention_name>
    <description>The intervention, called the SRH services CDS tool, includes integrating sexual and reproductive health guideline prompts into the electronic health record (EHR). The prompt guides clinicians to assess and broadly respond to adolescents' SRH behaviors through EHR survey data. Through the CDS tool, clinicians will be prompted to provide comprehensive and evidence-based sexual health care for teens including, for example: providing patient-facing education about sexual preventative health topics; facilitating clinician decision-making regarding and prescription of contraception or human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP); facilitating ordering of HIV and sexually transmitted infection (STI) laboratory tests to improve both risk-based and routine annual preventative screening; linking youth to health preventative services such as PrEP navigators or sexual health educators; and providing external referrals to adolescents, if needed.</description>
    <arm_group_label>CDS Tool Evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adolescent patients who meet the following inclusion criteria will be eligible: Sexual&#xD;
             and reproductive health clinical decision support (SRH CDS) tool is used at the&#xD;
             preventive care visit, age 13 years or older, English-speaking&#xD;
&#xD;
          -  Parents who meet the following inclusion criteria will be eligible: Attend a&#xD;
             preventive care visit with their adolescent child, are 18 years of age or older,&#xD;
             English-speaking, have a smartphone, personal contact information is available in&#xD;
             their child's electronic health record (EHR)&#xD;
&#xD;
          -  Clinicians who meet the following inclusion criteria will be eligible: Use the SRH CDS&#xD;
             tool at a preventative care visit with an adolescent patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢ Subjects who do not meet the above inclusion criteria will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian P. Jenssen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Primary care pediatrician and researcher</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian P. Jenssen, MD</last_name>
    <phone>215-554-4390</phone>
    <email>jenssenb@chop.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabrielle DiFiore, MPH</last_name>
    <phone>516-320-0193</phone>
    <email>difioreg@chop.edu</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

